Conducting Clinical Trials During a Pandemic

The growing number of clinical trials the kidney community has enjoyed over the past few years is endangered due to the COVID-19 pandemic. Concerns over the safety of trial participants and investigators are paramount and are leading to rapid changes in the conduct of clinical trials.

AKF Coronavirus Emergency Fund Provides Grants to Recent Kidney Transplant or Dialysis Patients

Donation_form_safety_net_emergency_patients.pngThe American Kidney Fund (AKF) opened applications for the AKF Coronavirus Emergency Fund on March 23, 2020. The fund aims to provide recent kidney transplant or current dialysis patients who demonstrate financial need with a one-time grant of $250 that may be used for food, medications, transportation, or other treatment essentials.

Update released from ASN President Anupam Agarwal to all ASN members regarding COVID-19

asn logo small_0.jpgOn Friday, March 20, ASN President Anupam Agarwal, MD, FASN issued an email to all ASN members addressing the COVID-19 pandemic and how ASN is responding.

Summary of ASN/NephJC Twitter Chat: COVID-19 and the Kidneys

Gretchen Brandt MD, FASN - Washington, DC

American Board of Internal Medicine Update on COVID-19, Spring Assessments Cancelled

ABIM announced that they have cancelled all spring assessments. No physician will have their certification status negatively impacted due to this decision. Click here for ABIM updates on COVID-19. Please contact ABIM directly with questions.

New CJASN Paper Identifies End Points for Primary Hyperoxaluria Clinical Trials

While there are many incentives to invest in rare diseases, well designed clinical trials are critical to getting the new therapies conceived by pharmaceutical companies to the people who need them.  

American Society of Nephrology’s Response to COVID-19

With the current spread of COVID-19 (Coronavirus) and due to the American Society of Nephrology’s international outreach representing 21,000 members in 131 countries, the organization has responded to the developments in the following ways in order to share important information with the nephrology community:

Rare Disease Day 2020: A Unique Moment for Drug Development for Rare Kidney Diseases

Rare Disease Day on Saturday, February 29, is intended to raise awareness of the thousands of rare diseases and the millions of people who live with them around the world. There are more than 100 rare kidney diseases, most of them without US Food and Drug Administration (FDA) approved therapies. Because of the lack of innovation in novel therapies to treat rare kidney diseases, many people who live with them face the prospect of progressing to kidney failure and enduring dialysis or waiting for a kidney transplant.

2019 in Review: Top 10 Kidney News Articles

2019 brought another successful year of nephrology coverage by ASN Kidney News and Kidney News Online. The two publications covered a broad spectrum of topics within nephrology and continued their strong record of informing the nephrology community.

New CDC-NTDS Online Learning Module: Managing Infection in an Outpatient Dialysis Facility

The Centers for Disease Control and Prevention (CDC) and Nephrologists Transforming Dialysis Safety (NTDS) have partnered to develop a fresh, new online learning module, Managing Infection in an Outpatient Dialysis Facility.

The module is available to all members of the nephrology care team, including physicians, nurses, fellows, technicians, patients, and kidney educators, via an open-access platform.